2024-01-012024-12-312024-12-31falseSC481291CRYOGENETICS TECHNOLOGIES UK LIMITED2025-04-1103210falseiso4217:GBPxbrli:pureSC4812912024-01-01SC4812912024-12-31SC4812912024-01-012024-12-31SC4812912023-01-01SC4812912023-12-31SC4812912023-01-012023-12-31SC481291bus:SmallEntities2024-01-012024-12-31SC481291bus:AuditExempt-NoAccountantsReport2024-01-012024-12-31SC481291bus:FullAccounts2024-01-012024-12-31SC481291bus:PrivateLimitedCompanyLtd2024-01-012024-12-31SC481291core:WithinOneYear2024-12-31SC481291core:AfterOneYear2024-12-31SC481291core:WithinOneYear2023-12-31SC481291core:AfterOneYear2023-12-31SC481291core:ShareCapital2024-12-31SC481291core:SharePremium2024-12-31SC481291core:RevaluationReserve2024-12-31SC481291core:OtherReservesSubtotal2024-12-31SC481291core:RetainedEarningsAccumulatedLosses2024-12-31SC481291core:ShareCapital2023-12-31SC481291core:SharePremium2023-12-31SC481291core:RevaluationReserve2023-12-31SC481291core:OtherReservesSubtotal2023-12-31SC481291core:RetainedEarningsAccumulatedLosses2023-12-31SC481291core:LandBuildings2024-12-31SC481291core:PlantMachinery2024-12-31SC481291core:Vehicles2024-12-31SC481291core:FurnitureFittings2024-12-31SC481291core:OfficeEquipment2024-12-31SC481291core:NetGoodwill2024-12-31SC481291core:IntangibleAssetsOtherThanGoodwill2024-12-31SC481291core:ListedExchangeTraded2024-12-31SC481291core:UnlistedNon-exchangeTraded2024-12-31SC481291core:LandBuildings2023-12-31SC481291core:PlantMachinery2023-12-31SC481291core:Vehicles2023-12-31SC481291core:FurnitureFittings2023-12-31SC481291core:OfficeEquipment2023-12-31SC481291core:NetGoodwill2023-12-31SC481291core:IntangibleAssetsOtherThanGoodwill2023-12-31SC481291core:ListedExchangeTraded2023-12-31SC481291core:UnlistedNon-exchangeTraded2023-12-31SC481291core:LandBuildings2024-01-012024-12-31SC481291core:PlantMachinery2024-01-012024-12-31SC481291core:Vehicles2024-01-012024-12-31SC481291core:FurnitureFittings2024-01-012024-12-31SC481291core:OfficeEquipment2024-01-012024-12-31SC481291core:NetGoodwill2024-01-012024-12-31SC481291core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-31SC481291core:ListedExchangeTraded2024-01-012024-12-31SC481291core:UnlistedNon-exchangeTraded2024-01-012024-12-31SC481291core:MoreThanFiveYears2024-01-012024-12-31SC481291core:Non-currentFinancialInstruments2024-12-31SC481291core:Non-currentFinancialInstruments2023-12-31SC481291dpl:CostSales2024-01-012024-12-31SC481291dpl:DistributionCosts2024-01-012024-12-31SC481291core:LandBuildings2024-01-012024-12-31SC481291core:PlantMachinery2024-01-012024-12-31SC481291core:Vehicles2024-01-012024-12-31SC481291core:FurnitureFittings2024-01-012024-12-31SC481291core:OfficeEquipment2024-01-012024-12-31SC481291dpl:AdministrativeExpenses2024-01-012024-12-31SC481291core:NetGoodwill2024-01-012024-12-31SC481291core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-31SC481291dpl:GroupUndertakings2024-01-012024-12-31SC481291dpl:ParticipatingInterests2024-01-012024-12-31SC481291dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-31SC481291core:ListedExchangeTraded2024-01-012024-12-31SC481291dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-31SC481291core:UnlistedNon-exchangeTraded2024-01-012024-12-31SC481291dpl:CostSales2023-01-012023-12-31SC481291dpl:DistributionCosts2023-01-012023-12-31SC481291core:LandBuildings2023-01-012023-12-31SC481291core:PlantMachinery2023-01-012023-12-31SC481291core:Vehicles2023-01-012023-12-31SC481291core:FurnitureFittings2023-01-012023-12-31SC481291core:OfficeEquipment2023-01-012023-12-31SC481291dpl:AdministrativeExpenses2023-01-012023-12-31SC481291core:NetGoodwill2023-01-012023-12-31SC481291core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-31SC481291dpl:GroupUndertakings2023-01-012023-12-31SC481291dpl:ParticipatingInterests2023-01-012023-12-31SC481291dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-31SC481291core:ListedExchangeTraded2023-01-012023-12-31SC481291dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-31SC481291core:UnlistedNon-exchangeTraded2023-01-012023-12-31SC481291core:NetGoodwill2024-12-31SC481291core:IntangibleAssetsOtherThanGoodwill2024-12-31SC481291core:LandBuildings2024-12-31SC481291core:PlantMachinery2024-12-31SC481291core:Vehicles2024-12-31SC481291core:FurnitureFittings2024-12-31SC481291core:OfficeEquipment2024-12-31SC481291core:AfterOneYear2024-12-31SC481291core:WithinOneYear2024-12-31SC481291core:ListedExchangeTraded2024-12-31SC481291core:UnlistedNon-exchangeTraded2024-12-31SC481291core:ShareCapital2024-12-31SC481291core:SharePremium2024-12-31SC481291core:RevaluationReserve2024-12-31SC481291core:OtherReservesSubtotal2024-12-31SC481291core:RetainedEarningsAccumulatedLosses2024-12-31SC481291core:NetGoodwill2023-12-31SC481291core:IntangibleAssetsOtherThanGoodwill2023-12-31SC481291core:LandBuildings2023-12-31SC481291core:PlantMachinery2023-12-31SC481291core:Vehicles2023-12-31SC481291core:FurnitureFittings2023-12-31SC481291core:OfficeEquipment2023-12-31SC481291core:AfterOneYear2023-12-31SC481291core:WithinOneYear2023-12-31SC481291core:ListedExchangeTraded2023-12-31SC481291core:UnlistedNon-exchangeTraded2023-12-31SC481291core:ShareCapital2023-12-31SC481291core:SharePremium2023-12-31SC481291core:RevaluationReserve2023-12-31SC481291core:OtherReservesSubtotal2023-12-31SC481291core:RetainedEarningsAccumulatedLosses2023-12-31SC481291core:NetGoodwill2023-01-01SC481291core:IntangibleAssetsOtherThanGoodwill2023-01-01SC481291core:LandBuildings2023-01-01SC481291core:PlantMachinery2023-01-01SC481291core:Vehicles2023-01-01SC481291core:FurnitureFittings2023-01-01SC481291core:OfficeEquipment2023-01-01SC481291core:AfterOneYear2023-01-01SC481291core:WithinOneYear2023-01-01SC481291core:ListedExchangeTraded2023-01-01SC481291core:UnlistedNon-exchangeTraded2023-01-01SC481291core:ShareCapital2023-01-01SC481291core:SharePremium2023-01-01SC481291core:RevaluationReserve2023-01-01SC481291core:OtherReservesSubtotal2023-01-01SC481291core:RetainedEarningsAccumulatedLosses2023-01-01SC481291core:AfterOneYear2024-01-012024-12-31SC481291core:WithinOneYear2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-31SC481291core:Non-currentFinancialInstrumentscore:CostValuation2024-12-31SC481291core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-31SC481291core:Non-currentFinancialInstrumentscore:CostValuation2023-12-31SC481291core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-31SC481291core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-31SC481291core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-31SC481291core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-31SC481291core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-31SC481291core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-31SC481291core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-31SC481291core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-31SC481291bus:Director12024-01-012024-12-31SC481291bus:Director22024-01-012024-12-31

CRYOGENETICS TECHNOLOGIES UK LIMITED

Registered Number
SC481291
(Scotland)

Unaudited Financial Statements for the Year ended
31 December 2024

CRYOGENETICS TECHNOLOGIES UK LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

RISBAKKEN, Kjersti
SAETERSMOEN, Eli

Registered Address

24 Blythswood Square
1st Floor
Glasgow
G2 4BG

Registered Number

SC481291 (Scotland)
CRYOGENETICS TECHNOLOGIES UK LIMITED
Statement of Financial Position
31 December 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors385,63015,517
Cash at bank and on hand178168
85,80815,685
Creditors amounts falling due within one year4(191,658)(180,069)
Net current assets (liabilities)(105,850)(164,384)
Total assets less current liabilities(105,850)(164,384)
Net assets(105,850)(164,384)
Capital and reserves
Called up share capital16,92016,920
Profit and loss account(122,770)(181,304)
Shareholders' funds(105,850)(164,384)
The financial statements were approved and authorised for issue by the Board of Directors on 11 April 2025, and are signed on its behalf by:
SAETERSMOEN, Eli
Director
Registered Company No. SC481291
CRYOGENETICS TECHNOLOGIES UK LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
At the balance sheet date, the company's balance sheet was overdrawn showing a net deficit. The major creditor of the company is the parent company. This company has confirmed that they will not demand repayment of this loan if it would prejudice the payment of external creditors. For this reason the company continues to adopt the going concern basis for these financial statements
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to the Income Statement.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
2.Average number of employees

20242023
Average number of employees during the year22
3.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables85,63015,517
Total85,63015,517
4.Creditors: amounts due within one year

2024

2023

££
Amounts owed to related parties175,427174,931
Taxation and social security13,5112,503
Other creditors10-
Accrued liabilities and deferred income2,7102,635
Total191,658180,069
5.Directors advances, credits and guarantees
On 1 January 2024 a director owed the Company £nil. During the period this director was advanced £nil and repaid £10. As at 31 December 2024 this director was owed £10 by the Company. No interest was charged on this loan. The loan is unsecured and repayable upon demand.
6.Related party transactions
As at 31 December 2024, Cryogenetics Technologies UK Limited had a long term loan balance outstanding with the parent entity which amounted to £175,427 (2023: £174,931). Interest is charged on the loan and there are no repayment terms
7.Controlling party
This company's parent undertaking and controlling party is Cryogenetics AS, a company registered in Norway, company number 985283885.